BOSTON, May 5, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at...
Hence then, the article about transcode therapeutics announces effective date for 1 for 28 reverse stock split was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split )
Also on site :
- NAVER Partners with Brookfield and NVIDIA to Expand Korea's National AI Factory Infrastructure Buildout
- Beach Hazards Statement issued July 24 at 10:35PM PDT until July 26 at 8:00PM PDT by NWS Los Angeles/Oxnard CA
- Trump fracasó estrepitosamente en la cena de corresponsales de la Casa Blanca, pero dejó claras sus intenciones